0001169245-12-000001.txt : 20120618 0001169245-12-000001.hdr.sgml : 20120618 20120618100621 ACCESSION NUMBER: 0001169245-12-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120618 DATE AS OF CHANGE: 20120618 EFFECTIVENESS DATE: 20120618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-40668 FILM NUMBER: 12911508 BUSINESS ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-535-8861 MAIL ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 D/A 1 primary_doc.xml X0705 D/A LIVE 0001169245 PhaseBio Pharmaceuticals Inc 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 610-608-8563 DELAWARE Phase Biosciences Inc DT BIOSCIENCES INC Corporation true Christopher Prior 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Joel Sussman 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Executive Officer Ashutosh Chilkoti 1001 Gloria Avenue Durham NC NORTH CAROLINA 27701 Executive Officer Director Clay Thorp 208 S. Mangum Street Suite 350 Durham NC NORTH CAROLINA 27701 Director Asish K Xavier c/o Johnson & Johnson Dev Corporation 410 George Street New Brunswick NJ NEW JERSEY 08901 Director Guy Fish 222 Berkeley Street 20th Floor Boston MA MASSACHUSETTS 02116 Director Robert Ingram 280 S. Mangum Street Suite 350 Durham NC NORTH CAROLINA 27701 Director Craig Rosen 370 Eagle Hill Road Pasadena MD MARYLAND 21122 Director Justin Klein 5425 Wisconsin Avenue Suite 800 Chevy Chase MD MARYLAND 20815 Director James Barrett 1119 St. Paul Street Baltimore MD MARYLAND 21202 Director Biotechnology Decline to Disclose 06 true 0001169245-10-000001 2009-12-22 true true false 0 48524067 48524067 0 false 17 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false PhaseBio Pharmaceuticals Inc /Christopher Prior, Ph.D./ Christopher Prior, Ph.D. Chief Executive Officer 2012-06-15